Subscription Status for Indigene IPO: Retail investors have outperformed non-institutional investors (NIIs) in the Indigene IPO, which has gotten off to a strong start. Since eligible employees who bid in the reservation segment are entitled to a ₹30 discount per equity share, the employee category is also filling up swiftly. Subscriptions are progressively sent to qualified institutional buyers (QIBs)
More about Indigene IPO
The Indegene IPO’s subscription status is 1.05 times as of 14:57 IST, per BSE statistics. Retail subscribers have subscribed 1.12 times, but NIIs have subscribed 2.19 times their share. 96% of employees and 1% of QIBs have subscribed.
See also: Indigene IPO Open: Price, Date, Lot Size, Review, GMP, Subscription Status, and Additional Information. Do You Think You Should Apply?
The Indegene IPO will close on Wednesday, May 8, having opened for subscriptions today, Monday, May 6. The fixed price range for each equity share is between ₹430 and ₹452. On Friday, May 3, 36 anchor investors contributed ₹548.77 crores to the Indigene IPO, with an upper price range of ₹452 per equity share.
A maximum of 50% has been set aside for QIBs, 15% for NIIs, and 35% for retail investors in the public offering.
Digital services are offered by Indegene Limited to the life sciences industry. In addition to managing diagnostic tests, pharmacovigilance, regulatory submissions, drug research, and sales and marketing assistance, they also help with complaint handling.
Indigene IPO Reviews
The company offers services that can be divided into several categories, including enterprise commercial solutions, omnichannel activation, enterprise medical solutions, enterprise clinical solutions, and consultant services.
Live Subscription Status for Indigene IPO
As per data from the BSE at 14:57 IST, the Indegene IPO garnered bids for 3,02,10,081 shares, surpassing the 2,88,66,677 shares available for sale.
Out of the 1,44,60,759 shares allotted for the category, 1,62,48,078 shares have been bid on by retail investors.
NIIs have received bids for 1,35,86,892 shares for this segment, out of the 61,97,468 shares that are being offered.
Out of the 3,12,500 shares reserved, bids for 3,01,389 shares have been received by the employee category.
In the QIB category, 73,722 shares have been bid on out of the 78,95,950 shares that are available.
Info on the Indigene IPO
The ₹1,841.76 crore Indigene IPO consists of a new ₹760 crore issue in addition to an offer for sale (OFS) by stockholders selling 23,932,732 equity shares.
A total of 1,118,596 equity shares from Manish Gupta, 3,600,000 equity shares from Vida Trustees Private Limited, 3,233,818 equity shares from Dr. Rajesh Baskaran Nayar, 1,151,454 equity shares from Anita Nayar, 2,657,687 equity shares from BPC Genesis Fund I SPV Limited, 1,378,527 equity shares from BPC Genesis Fund A SPV Limited, and 10,792,650 equity shares from CA Don Investments are among the parties selling their stakes.
The business will use the net proceeds to support the following goals: general corporate purposes, organic expansion, funding for capital expenditure requirements of our firm and its subsidiaries, and repayment or payback of loans from ILSL Holdings, Inc. and Indegene, Inc. Today’s Indigene IPO GMP
The Grey Market Premium, or Indegene IPO Grey Market Premium (GMP), is +262. This suggests that the Indegene share was selling for ₹262 more on the gray market, according to InvestorGen.com.
It is anticipated that Indigene shares will be listed at ₹714 per share, which is 57.96% more than the IPO price of ₹452, after taking into account the top price band of the IPO and the present premium in the grey market.
Ten sessions of previous grey market activity indicate a growing IPO GMP, which suggests a favorable outlook for listing. The minimum GMP is estimated by analysts at InvestorGen.com to be ₹160, while the highest GMP is ₹266.
An investor’s readiness to pay more than the issue price is shown by the grey market premium.